Metastatic malignant melanoma in a patient taking interleukin-1 receptor antagonist

Joint Bone Spine. 2006 May;73(3):333-4. doi: 10.1016/j.jbspin.2005.08.004. Epub 2006 Feb 28.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antimalarials / therapeutic use
  • Arthritis, Rheumatoid / drug therapy
  • Drug Therapy, Combination
  • Humans
  • Interleukin 1 Receptor Antagonist Protein
  • Lymphatic Metastasis*
  • Male
  • Melanoma* / chemically induced
  • Melanoma* / pathology
  • Melanoma* / secondary
  • Prednisone / therapeutic use
  • Receptors, Interleukin-1 / antagonists & inhibitors*
  • Sialoglycoproteins / adverse effects*
  • Sialoglycoproteins / therapeutic use
  • Skin Neoplasms* / chemically induced
  • Skin Neoplasms* / pathology
  • Skin Neoplasms* / physiopathology

Substances

  • Antimalarials
  • IL1RN protein, human
  • Interleukin 1 Receptor Antagonist Protein
  • Receptors, Interleukin-1
  • Sialoglycoproteins
  • Prednisone